We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$82.6M
Cap. Flow
+$147M
Cap. Flow %
6.86%
Top 10 Hldgs %
24.87%
Holding
174
New
31
Increased
73
Reduced
40
Closed
27

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$26M
2
FISV
Fiserv Inc
FISV
+$24M
3
OMC icon
Omnicom Group
OMC
+$19.5M
4
OC icon
Owens Corning
OC
+$19.2M
5
MOS icon
The Mosaic Company
MOS
+$18.3M

Top Sells

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$24.3M
2
BKH icon
Black Hills Corp
BKH
+$19.6M
3
SEE
Sealed Air
SEE
+$15.5M
4
UHS icon
Universal Health Services
UHS
+$15M
5
GOLD
Gold.com Inc
GOLD
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 20.83%
2 Healthcare 17.07%
3 Consumer Discretionary 14.96%
4 Materials 11.78%
5 Industrials 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COP icon
51
ConocoPhillips
COP
$148B
$14.4M 0.67%
154,195
+60
+0% +$5.43K
M icon
52
Macy's
M
$6.55B
$14.4M 0.67%
653,659
+1,200
+0.2% +$24.6K
BPOP icon
53
Popular Inc
BPOP
$11.1B
$14.3M 0.67%
115,198
-2,619
-2% -$310K
BAX icon
54
Baxter International
BAX
$14.4B
$14.3M 0.66%
746,651
+379,996
+104% +$7.6M
SSTK icon
55
Shutterstock
SSTK
$217M
$14M 0.65%
734,949
-1,902
-0.3% -$40.7K
CENTA icon
56
Central Garden & Pet Co Class A
CENTA
$2.39B
$13.7M 0.64%
+471,015
New +$13.6M
IART icon
57
Integra LifeSciences
IART
$1.33B
$13.1M 0.61%
1,055,941
+463,729
+78% +$6.17M
HELE icon
58
Helen of Troy
HELE
$680M
$12.6M 0.59%
593,310
+38,325
+7% +$782K
CAL icon
59
Caleres
CAL
$486M
$12.6M 0.58%
1,031,874
+160,274
+18% +$1.97M
CART icon
60
Maplebear
CART
$11.9B
$12.1M 0.56%
269,326
-210,078
-44% -$8.6M
ZBH icon
61
Zimmer Biomet
ZBH
$18.7B
$12M 0.56%
+133,858
New +$12.7M
CRM icon
62
Salesforce
CRM
$162B
$11.8M 0.55%
44,710
-1,017
-2% -$253K
VSTS icon
63
Vestis
VSTS
$1.83B
$11.5M 0.54%
1,731,536
+449,497
+35% +$2.62M
DCH
64
Dauch Corp
DCH
$1.58B
$11.4M 0.53%
1,779,895
+740,998
+71% +$4.61M
PRKS icon
65
United Parks & Resorts
PRKS
$2.07B
$11.2M 0.52%
309,008
+266,375
+625% +$11.1M
PATH icon
66
UiPath
PATH
$8.08B
$10.9M 0.51%
663,434
-434,705
-40% -$6.77M
JACK icon
67
Jack in the Box
JACK
$340M
$10.8M 0.5%
568,079
-155,068
-21% -$2.8M
VSH icon
68
Vishay Intertechnology
VSH
$5.08B
$10.1M 0.47%
695,125
-15,823
-2% -$240K
HLF icon
69
Herbalife
HLF
$1.21B
$9.9M 0.46%
768,031
+347,401
+83% +$3.68M
WT icon
70
WisdomTree
WT
$3.36B
$9.87M 0.46%
+809,902
New +$9.78M
SBH icon
71
Sally Beauty Holdings
SBH
$1.57B
$9.81M 0.46%
688,015
-3,021
-0.4% -$45.5K
ACH
72
Accendra Health
ACH
$107M
$9.81M 0.46%
3,502,345
+753,223
+27% +$2.69M
QTRX icon
73
Quanterix
QTRX
$114M
$9.57M 0.45%
1,505,208
+112,203
+8% +$697K
RPD icon
74
Rapid7
RPD
$776M
$9.55M 0.44%
627,983
+11,283
+2% +$186K
FVRR icon
75
Fiverr
FVRR
$327M
$9.44M 0.44%
477,892
-144,539
-23% -$3.11M
1 2
3
4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Invenomic Capital Management held 174 positions worth $2.15B, up 4% from $2.07B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $147M of net new capital in Q4 2025, opening 31 new positions and adding to 73 existing holdings. Its largest new stake was Fiserv Inc: 287,266 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $13.2M trimmed.

  • Invenomic Capital Management's largest Q4 2025 buy was Fiserv Inc: 287,266 shares worth $19.3M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q4 2025, an estimated $26M increase.
  • Invenomic Capital Management's biggest Q4 2025 reduction was Verizon, cutting an estimated $13.2M.
  • Invenomic Capital Management fully exited Haemonetics in Q4 2025, selling an estimated $24.3M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.15B portfolio in Q4 2025.
  • Invenomic Capital Management opened 31 new positions and closed 27 in Q4 2025.
  • Invenomic Capital Management's portfolio value rose 4% quarter-over-quarter to $2.15B.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.